Dimensional Fund Advisors
OXFD

Dimensional Fund Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Dimensional Fund Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-333,437
Closed -$5.82M – 3434
2020
Q4 		$5.82M Buy
333,437
+10,795
+3% +$151K ﹤0.01% 2474
2020
Q3 		$3.77M Buy
322,642
+3,161
+1% +$41.9K ﹤0.01% 2541
2020
Q2 		$4.15M Buy
319,481
+22,678
+8% +$272K ﹤0.01% 2539
2020
Q1 		$2.75M Buy
296,803
+28,234
+11% +$395K ﹤0.01% 2601
2019
Q4 		$4.46M Buy
268,569
+112,868
+72% +$1.83M ﹤0.01% 2648
2019
Q3 		$2.59M Buy
155,701
+39,637
+34% +$548K ﹤0.01% 2794
2019
Q2 		$1.6M Buy
+116,064
New +$1.78M ﹤0.01% 2953

Dimensional Fund Advisors's OXFD Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 333,437 shares — an estimated $5.82M sold.

Dimensional Fund Advisors first reported a position in OXFD in Q2 2019 and held it in 7 quarters. The position peaked at $5.82M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Dimensional Fund Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 333,437 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $5.82M.
  • Dimensional Fund Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 7 quarters.
  • Dimensional Fund Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $5.82M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.